Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Change in Receivables (2016 - 2025)

Xtant Medical Holdings has reported Change in Receivables over the past 16 years, most recently at -$1.2 million for Q3 2025.

  • Quarterly Change in Receivables fell 120.36% to -$1.2 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $6.3 million through Sep 2025, up 244.85% year-over-year, with the annual reading at $755000.0 for FY2024, 91.36% down from the prior year.
  • Change in Receivables was -$1.2 million for Q3 2025 at Xtant Medical Holdings, down from $3.8 million in the prior quarter.
  • Over five years, Change in Receivables peaked at $3.9 million in Q3 2023 and troughed at -$1.2 million in Q3 2025.
  • The 5-year median for Change in Receivables is $903000.0 (2021), against an average of $1.0 million.
  • Year-over-year, Change in Receivables plummeted 215.61% in 2021 and then soared 2068.06% in 2025.
  • A 5-year view of Change in Receivables shows it stood at $903000.0 in 2021, then grew by 8.42% to $979000.0 in 2022, then skyrocketed by 72.52% to $1.7 million in 2023, then tumbled by 62.88% to $627000.0 in 2024, then tumbled by 296.81% to -$1.2 million in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Change in Receivables are -$1.2 million (Q3 2025), $3.8 million (Q2 2025), and $3.1 million (Q1 2025).